Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

37
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
37
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

966
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
966
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

37
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
37
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

35
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
35
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

350
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
350
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

1.2K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic cardiomyopathy in pediatrics.

Reviews in cardiovascular medicine·2019
Same author

Cardiorespiratory synchronism in estimation of regulatory and adaptive organism status.

Journal of integrative neuroscience·2016
Same author

On the conscious control of the human heart.

Journal of integrative neuroscience·2012
Same author

Interaction of brain and intracardiac levels of rhythmogenesis hierarchical system at heart rhythm formation.

Journal of integrative neuroscience·2009
Same author

Alternative view on the mechanism of cardiac rhythmogenesis.

Heart, lung & circulation·2005
Same author

Hierarchy of the heart rhythmogenesis levels is a factor in increasing the reliability of cardiac activity.

Medical hypotheses·2005

Related Experiment Video

Updated: Oct 19, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.2K

Dyslipidemia in pediatrician's practice.

Alla V Burlutskaya1, Victoria E Tril1, Lily V Polischuk2

  • 1Department of Pediatrics №2, Kuban State Medical University, 350063 Krasnodar, Russia.

Reviews in Cardiovascular Medicine
|September 26, 2021
PubMed
Summary

Atherosclerosis, a leading cause of death, begins in childhood. Early detection of lipid metabolism disorders (dyslipidemias) in children is crucial for preventing future cardiovascular diseases.

Keywords:
AdolescentsAtherosclerosisChildrenDyslipidemiaRisk factors

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.7K

Related Experiment Videos

Last Updated: Oct 19, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.2K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.7K

Area of Science:

  • Cardiology
  • Pediatric Health
  • Metabolic Disorders

Background:

  • Atherosclerosis is a leading cause of cardiovascular mortality, with pathological processes beginning in early life.
  • Risk factors for atherosclerosis, including dyslipidemias, are prevalent in children and adolescents.
  • Childhood lipid profiles predict adult cardiovascular risk, necessitating early intervention.

Purpose of the Study:

  • To investigate the pathophysiological basis of lipid and lipoprotein metabolism.
  • To examine the epidemiology of dyslipidemias in children and adolescents.
  • To review dyslipidemia classification, diagnosis, and management strategies for pediatric populations.

Main Methods:

  • Epidemiological studies on pediatric dyslipidemia prevalence.
  • Analysis of pathophysiological mechanisms of lipid metabolism.
  • Review of current diagnostic and therapeutic guidelines for pediatric dyslipidemias.

Main Results:

  • Dyslipidemias are highly prevalent in over 70% of children and adolescents globally.
  • Childhood dyslipidemias are significant predictors of adult cardiovascular disease.
  • Early identification of dyslipidemia enables preclinical risk stratification.

Conclusions:

  • Dyslipidemia is a critical, early-onset risk factor for atherosclerotic cardiovascular diseases.
  • Timely diagnosis and management of pediatric dyslipidemias are essential for long-term cardiovascular health.
  • Phenotyping dyslipidemias in youth aids in identifying individuals at high risk for future cardiovascular pathology.